367 related articles for article (PubMed ID: 26330296)
1. Myeloid-derived suppressor cells in B cell malignancies.
Yazdani Y; Mohammadnia-Afrouzi M; Yousefi M; Anvari E; Ghalamfarsa G; Hasannia H; Sadreddini S; Jadidi-Niaragh F
Tumour Biol; 2015 Sep; 36(10):7339-53. PubMed ID: 26330296
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
3. Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts.
Maenhout SK; Van Lint S; Emeagi PU; Thielemans K; Aerts JL
Int J Cancer; 2014 Mar; 134(5):1077-90. PubMed ID: 23983191
[TBL] [Abstract][Full Text] [Related]
4. Suppression of T cells by myeloid-derived suppressor cells in cancer.
Chen J; Ye Y; Liu P; Yu W; Wei F; Li H; Yu J
Hum Immunol; 2017 Feb; 78(2):113-119. PubMed ID: 27939507
[TBL] [Abstract][Full Text] [Related]
5. The immunobiology of myeloid-derived suppressor cells in cancer.
Motallebnezhad M; Jadidi-Niaragh F; Qamsari ES; Bagheri S; Gharibi T; Yousefi M
Tumour Biol; 2016 Feb; 37(2):1387-406. PubMed ID: 26611648
[TBL] [Abstract][Full Text] [Related]
6. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
7. Antigen specificity of immune suppression by myeloid-derived suppressor cells.
Solito S; Bronte V; Mandruzzato S
J Leukoc Biol; 2011 Jul; 90(1):31-6. PubMed ID: 21486906
[TBL] [Abstract][Full Text] [Related]
8. β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses.
Ning Y; Xu D; Zhang X; Bai Y; Ding J; Feng T; Wang S; Xu N; Qian K; Wang Y; Qi C
Int J Cancer; 2016 Jun; 138(11):2713-23. PubMed ID: 26773960
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-derived suppressor cell heterogeneity in human cancers.
Solito S; Marigo I; Pinton L; Damuzzo V; Mandruzzato S; Bronte V
Ann N Y Acad Sci; 2014 Jun; 1319():47-65. PubMed ID: 24965257
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
[TBL] [Abstract][Full Text] [Related]
11. PI3Kγ Activates Integrin α
Foubert P; Kaneda MM; Varner JA
Cancer Immunol Res; 2017 Nov; 5(11):957-968. PubMed ID: 28963139
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer.
Katoh H; Watanabe M
Mediators Inflamm; 2015; 2015():159269. PubMed ID: 26078490
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-derived suppressor cells in hematological malignancies: friends or foes.
Lv M; Wang K; Huang XJ
J Hematol Oncol; 2019 Oct; 12(1):105. PubMed ID: 31640764
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells.
Bianchi G; Borgonovo G; Pistoia V; Raffaghello L
Histol Histopathol; 2011 Jul; 26(7):941-51. PubMed ID: 21630223
[TBL] [Abstract][Full Text] [Related]
15. Insights into Myeloid-Derived Suppressor Cells in Inflammatory Diseases.
Kwak Y; Kim HE; Park SG
Arch Immunol Ther Exp (Warsz); 2015 Aug; 63(4):269-85. PubMed ID: 25990434
[TBL] [Abstract][Full Text] [Related]
16. Functional Diversity of Myeloid-Derived Suppressor Cells: The Multitasking Hydra of Cancer.
Jayakumar A; Bothwell ALM
J Immunol; 2019 Sep; 203(5):1095-1103. PubMed ID: 31427398
[TBL] [Abstract][Full Text] [Related]
17. Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.
Yan J; Tingey C; Lyde R; Gorham TC; Choo DK; Muthumani A; Myles D; Weiner LP; Kraynyak KA; Reuschel EL; Finkel TH; Kim JJ; Sardesai NY; Ugen KE; Muthumani K; Weiner DB
Cancer Gene Ther; 2014 Dec; 21(12):507-17. PubMed ID: 25394503
[TBL] [Abstract][Full Text] [Related]
18. Myeloid derived suppressor cells and their role in tolerance induction in cancer.
Fujimura T; Mahnke K; Enk AH
J Dermatol Sci; 2010 Jul; 59(1):1-6. PubMed ID: 20570112
[TBL] [Abstract][Full Text] [Related]
19. Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments.
Blidner AG; Salatino M; Mascanfroni ID; Diament MJ; Bal de Kier Joffé E; Jasnis MA; Klein SM; Rabinovich GA
J Immunol; 2015 Apr; 194(7):3452-62. PubMed ID: 25740944
[TBL] [Abstract][Full Text] [Related]
20. Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions.
Abrams SI; Netherby CS; Twum DY; Messmer MN
J Interferon Cytokine Res; 2016 Jul; 36(7):442-53. PubMed ID: 27379866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
